RZLT

Conviction 42HealthcareScan · Thu, Sep 24, 2026

Rezolute, Inc. (RZLT) closed at $3.95 (-1.25%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 37, RS Rating 38, -63.9% from its 52-week high, +82.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

RZLT$3.95-1.25%

ResistanceSupportVol 14

Vol MA14 1.68M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Rezolute, Inc.PHARMACEUTICAL PREPARATIONSwww.rezolutebio.com ↗

Price3.95

Change-1.25%

Gap+0.00%

Rel volume3.56×

Avg volume1.44M

Avg $ vol5.97M

SMA 204.27

SMA 504.59

SMA 2003.76

Price vs 50-13.90%

Price vs 200+5.07%

MA stackmixed

50/200 cross—

Supertrenddown · 4.63

RSI (14)37

MACD hist-0.02

MACD cross—

Stoch %K / %D30 / 35

ADX (14)25

+DI / −DI13 / 26

RSI divergence—

MACD divergenceBullish

ATR %6.51%

ADR %5.66%

52w high10.94

52w low1.40

From 52w high-63.89%

Above 52w low+182.14%

New 52w highNo

SqueezeOff

Bollinger width29.08%

%B0.24

Donchian pos20.13%

Donchian high5.08

Donchian low3.67

AVWAP (52w high)3.17

vs AVWAP high+24.49%

AVWAP (52w low)2.80

vs AVWAP low+41.12%

OBV trendDown

Chaikin MF (20)-0.15

Today vs 20d3.56×

Avg vol (14d)1.68M

Avg vol (20d)1.44M

Avg $ vol (20d)5.97M

Market cap382.05M

RS Rating38 / 99

RS 3m (vs SPY)-25.96%

RS 6m (vs SPY)+7.40%

RS line new highNo

Trend template3/8

Technical rank54.7

1 week+0.00%

1 month-21.16%

3 months-21.47%

6 months+24.21%

1 year-53.64%

YTD+82.45%

P/E-4.92

P/B3.79

P/S—

P/FCF-5.90

EPS-0.7500

Div yield—

ROE-77.06%

ROA-68.75%

Debt/Eq0.05

Current9.68

EV/EBITDA-4.54

Gross margin—

Net margin—

Rev growth—

EPS growth-4.27%

Price target5.50

Target upside39.24%

Analyst ratingBuy

Institutional95.29%

Ent. value376.45M

Revenue—

Net income-16.17M

Gross profit—

Free cash flow-64.79M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees71

ListedFri, Dec 23, 2011

Free float81.78M

Float %85.5%

Short interest17M

Days to cover11.0d

Short volume53.2%

Squeeze score89 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.16 vs −$0.13

Last surprise-23.1% miss

Setup gradeD

Conviction42 / 100

Pattern quality—

Tech rank54.7 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.44

Support3.82

Days since event—

Candle confirm—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RZLT

All disclosures →

No recent disclosed trades by Congress in RZLT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RZLT

Insider	Side	Shares	Value	Traded	Filed
Elam Nevan C CEO · Common Shares · 2026-07-02	Tax	8K	$40K	2026-07-02	2026-07-07
Evans Daron CFO · Common Shares · 2026-07-02	Tax	3.06K	$15K	2026-07-02	2026-07-07
ROBERTS BRIAN KENNETH Chief Medical Officer · Common Shares · 2026-07-02	Tax	3.06K	$15K	2026-07-02	2026-07-07

SEC filings

EDGAR filings in RZLT · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.